The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic Experience
Abstract
PHEOCHROMOCYTOMA, a catecholamine-producing tumor arising in the adrenal medulla, has an estimated incidence of two to eight cases per million persons annually (1, 2). Its clinical hallmark is sustained or intermittent hypertension often associated with paroxysmal symptoms (3). Pheochromocytoma should also be considered if a patient has labile hypertension, hypertension resistant to antihypertensive therapy, or paroxysmal symptoms (“spells”) (3, 4). Correct diagnosis is important because resection of the tumor dramatically reverses the clinical symptoms and may cure the hypertension (5). A missed or delayed diagnosis may cause considerable morbidity and mortality (5, 6). Clinically significant pheochromocytoma was first recognized in 1926 when Cesar Roux in Switzerland and Charles H. Mayo in the United States successfully removed pheochromocytomas to cure the catecholamine-associated symptom complex (7, 8). A biochemical assessment of catecholamine hypersecretion was not possible in 1926. Since then, the diagnostic approach has progressed from clinical impressions and exploratory laparotomies to histamine stimulation and phentolamine suppression tests in the 1940s, crude catecholamine measurements and iv urograms in the 1950s and 1960s, and refined measurements of catecholamine levels and computerized imaging in the 1970s and 1980s. Most laboratories now measure catecholamines by HPLC with electrochemical detection or gas chromatography and mass spectrometry. Catecholamines and their metabolites can be measured in the blood or urine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M., & Mueller, P. R. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.1.9648789 · Cited by 693
Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503
Self-citationMANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
Self-citationOccurrence of Pheochromocytoma in Rochester, Minnesota, 1950 Through 1979
Beard, A. M., Sheps, S. G., Kurland, L. T., Carney, J. A., & Lie, J. T. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18873-3 · Cited by 402
A simple analysis for normetanephrine and metanephrine in urine
Plsano, J. J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90146-7 · Cited by 348
Imaging of Adrenal Incidentalomas: Current Status
Dunnick, N. R., & Korobkin, M. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.3.1790559 · Cited by 307
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection
Lenders, J. W., Eisenhofer, G., Armando, I., Keiser, H. R., Goldstein, D. S., & Kopin, I. J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.1.97 · Cited by 220
Pheochromocytoma in Sweden 1958–1981: An Analysis of the National Cancer Registry Data
STENSTRÖM, G., & SVÅRDSUDD, K. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02755.x · Cited by 213
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Stenström, G., & Svardsudd, K. F. (1986) · PubMed · Cited by 212
Moyer, T. P., Jiang, N. S., Tyce, G. M., & Sheps, S. G. (1979) · Clinical Chemistry · doi:10.1093/clinchem/25.2.256 · Cited by 201
Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma
Raber, W., Raffesberg, W., Bischof, M., Scheuba, C., Niederle, B., Gasic, S., Waldhäusl, W., & Roden, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2957 · Cited by 182
Urinary excretion of catecholamines and their metabolites in pheochromocytoma
Crout, J. R., Pisano, J. J., & Sjoerdsma, A. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90609-3 · Cited by 171
Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
Weise, M., Merke, D. P., Pacák, K., Walther, M. M., & Eisenhofer, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8446 · Cited by 123
Taylor, R. L., & Singh, R. J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.533 · Cited by 97
Clinically Unsuspected Pheochromocytomas
Krane, N. K. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130064008 · Cited by 79
Young, W. F., & Maddox, D. E. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.757 · Cited by 67
Self-citationBiochemical Diagnosis of Pheochromocytoma—Is it Time to Switch to Plasma-Free Metanephrines?
Eisenhofer, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021913 · Cited by 63
Young, W. F. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90035-d · Cited by 62
Self-citationQuantification of Unconjugated Metanephrines in Human Plasma without Interference by Acetaminophen
Roden, M., Raffesberg, W., Raber, W., Bernroider, E., Niederle, B., Waldhäusl, W. K., & Gasic, S. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.1061 · Cited by 52
ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine.
Weinkove, C. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.4.269 · Cited by 43
Phaeochromocytoma: how to catch a moonbeam in your hand
Young, W. F. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360028 · Cited by 34
Self-citationCurrent concepts in imaging of adrenal masses
Teeger, S., Papanicolaou, N., & Vaughan, E. D. (1999) · World Journal of Urology · doi:10.1007/s003450050097 · Cited by 11
Cited by
Protein–inorganic hybrid nanoflowers
Ge, J., Lei, J., & Zare, R. N. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.80 · Cited by 1,200
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,096
Self-citationThe diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Discovery of Protein Biomarkers for Renal Diseases
Hewitt, S. M., Dear, J., & Star, R. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129114.92265.32 · Cited by 295
Ken-Dror, G., Wood, M., Fluck, D., Sharma, P., Fry, C. H., & Han, T. S. (2021) · JRSM Cardiovascular Disease · doi:10.1177/2048004021992191 · Cited by 2
Metadata
- Authors
- Kudva, Y. C., Sawka, A. M., & Young, W. F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-10-01
- Volume
- 88
- Issue
- 10
- Pages
- 4533-4539
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2110113876
- Cited by
- 259
- References
- 24
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.